Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Wilmington Star-News on MSN
How Southport can cope with its grief and trauma following a mass shooting
A mass shooting occurred in the small, seaside city of Southport on Sept. 27, and its impact may be felt for weeks or months ...
Disasters or emergency situations not only cause physical harm but also significantly affect mental health. One in every five ...
3don MSN
Some VA therapists and patients say their treatment sessions are being limited, raising alarm
An edge comes to Michael’s voice when he speaks about his time serving in Afghanistan and his struggles living with post-traumatic stress disorder.
FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix’s investigational intranasal potentiated oxytocin ...
CHATHAM, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a ...
The Chosun Ilbo on MSN
Parent's Malicious Complaints Over Smoking Discipline Prompt Teacher Protection Calls
A parent of a high school student has been reported for filing complaints accusing a teacher of human rights violations and child abuse after the teacher disciplined the student for smoking. On the ...
Topline results were announced from a phase 3 trial evaluating BNC210 in patients with social anxiety disorder.
PRESSADVANTAGE – Moment of Clarity has published a new resource titled “Using Ketamine for Anxiety and PTSD Treatment“, now ...
News Medical on MSN
Psychedelics offer new therapeutic framework for stress-related psychiatric disorders
A peer-reviewed viewpoint article published in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results